| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N03AA02 |
| UNII: | YQE403BP4D |
| InChI Key | DDBREPKUVSBGFI-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C12H12N2O3 |
| Molecular Weight | 232.24 |
| AlogP | 0.7 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 75.27 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 17.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 2500 | - | - | 5 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 11 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Seizures | 3 | D012640 | ClinicalTrials |
| Neonatal Abstinence Syndrome | 3 | D009357 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Anxiety | 3 | D001007 | ClinicalTrials |
| Dementia | 3 | D003704 | ClinicalTrials |
| Status Epilepticus | 3 | D013226 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Neutropenia | 1 | D009503 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 8069 |
| ChEMBL | CHEMBL40 |
| DrugBank | DB01174 |
| DrugCentral | 2134 |
| EPA CompTox | DTXSID5021122 |
| FDA SRS | YQE403BP4D |
| Human Metabolome Database | HMDB0015305 |
| Guide to Pharmacology | 2804 |
| KEGG | C07434 |
| PDB | UQA |
| PharmGKB | PA450911 |
| SureChEMBL | SCHEMBL16583 |
| ZINC | ZINC000095588079 |